Top compounds associated with response to RANGRF


Feature Type Standardized
Nominal ANOVA
mRNA ATRA CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA BRD-K88742110 CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA Topotecan CCLE pan-cancer AAC 0.15 0.0007
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA Irinotecan gCSI pan-cancer AAC 0.18 0.0009
mRNA TG-100-115 CTRPv2 pan-cancer AAC 0.13 0.0009
mRNA Topotecan CTRPv2 pan-cancer AAC 0.11 0.001
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.12 0.001
Download CSV